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Abstract
Background: Vitamin D deficiency has been often observed in obese persons. One of the mechanisms suggested
for low vitamin D status in obesity was decreased bioavailability of vitamin D (VD) due to sequestration in adipose
tissue. However, only few studies have investigated this mechanism via quantifying vitamin D levels from tissues
from the obese.
Methods: Six-wk-old C57BL/6 mice were fed 10 or 45% kcal fat (CON or HFD) diets containing 50, 1000 or 25,000 IU
vitamin D3/kg diet (LVd, CVd or HVd) for 13 wks. Serum 25-hydroxyvitamin D (25(OH)D) levels were determined by
radioimmunoassay and liver and adipose tissue cholecalciferol (VD3) and 25-hydrocholecalciferol (25(OH)D3) levels
were measured by LC-MS/MS. mRNA levels of jejunal Mttp, Cd36, Sr-b1, Npc1l1, and Abca1 and liver and adipose
tissue 25-hydroxylases (Cyp2r1 and Cyp27a1) were determined by real-time PCR.
Results: Serum 25(OH)D levels were affected by dietary vitamin D content but differential effects were observed
between HFD and CON groups. When vitamin D intake was at a supplementary level, the HFD-HVd group had
lower serum 25(OH)D levels than the CON-HVd group, while there was no significant difference between the HFD
and CON groups fed LVd or CVd. Total amount of VD3 in liver and adipose tissue were significantly higher in HFD-
HVd group compared with the CON-HVd group. However, no difference in total amount of tissue VD3 was
observed between the CON and HFD groups fed CVd. In jejunum, mRNA levels of Mttp and Abca1 were
significantly higher in HFD groups than CON groups. There was no difference in mRNA levels of liver 25-
hydroxylases by both dietary fat amount and vitamin D content.
Conclusion: A significant amount of VD3 seemed to be stored in the liver and adipose tissue when dietary vitamin
D is at a supplementation level; thus excess body adiposity could contribute to relatively low serum 25(OH)D level
when vitamin D was supplemented.
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Background
Vitamin D (VD) insufficiency (serum 25-hydroxyvitamin
D (25(OH)D) levels lower than 30 ng/mL) is highly
prevalent worldwide and it has been estimated that more
than 30–50% of the populations in Europe and the US,
and more than 50% in East Asia are VD insufficient or
deficient [1–3]. Low serum 25(OH)D levels have been
observed in obese persons and circulating 25(OH)D
levels correlated inversely with body mass index and
body fat mass [4–6]. It has been reported that the preva-
lence of VD deficiency was 35% higher in obese persons
and 24% higher in overweight persons compared with
non-obese persons [7]. Although several mechanisms
such as low ultraviolet B (UVB) exposure of obese
people and VD sequestration or dilution into adipose
tissue have been proposed for the higher prevalence of
VD deficiency among the obese, the causes of their low
25(OH)D levels are still inconclusive.
Early studies on adipose tissue using animals or
humans supplemented with 14C-radiolabeled cholecalcif-
erol (VD3) followed by measuring the radioactivity have
shown that VD and its metabolites are stored in adipose
tissue [8, 9]. Wortsman et al. [10] observed that serum
25(OH)D levels increased more in a non-obese group
compared with an obese group when they were on ex-
posure to UVB or when VD supplements were given to
them. Thus, it has been suggested that adiposity could
lead to the decreased bioavailability of VD due to VD
sequestration in body fat. Furthermore, Drincic et al. [6]
proposed volumetric dilution (VD distributed over a
larger body size) as the reason for low serum 25(OH)D
concentration in the obese. An inverse association be-
tween serum 25(OH)D levels and body fat mass using
the hyperbolic fit model (the mathematical expression of
dilution) was used for explaining low VD status associ-
ated with obesity. Although VD sequestration or volu-
metric dilution might explain the VD deficiency
observed in the obese, few studies have directly demon-
strated these hypotheses by quantifying VD levels in adi-
pose tissue and comparing VD levels between obese and
non-obese subjects due to the difficulty in measuring
fat-soluble VD from small quantities of fat tissue [11–
13]. In human studies, it is difficult to control for the
variables related to VD synthesis in the skin, such as
UVB exposure time, usage of sunblock, season, and age.
Therefore, environmentally controllable animal studies
are needed to provide evidence for how obesity affects
the storage of VD in soft tissues and VD metabolism.
VD is fat-soluble and is usually absorbed with dietary
fat by passive diffusion in proximal jejunum and distal
ileum [14]. Dietary VD is packaged into chylomicrons
with triglycerides, cholesterol, and other lipids within
the intestine wall, and this process is dependent on
microsomal triglyceride transfer protein (MTP) [15–17].
VD contained in chylomicron is secreted into lymphatic
system and some of them are taken into adipose tissue
and liver during chylomicron hydrolysis by lipoprotein
lipase (LPL). Fat intake could influence the absorption of
dietary VD in the small intestine and the impact of the
fat amount in a meal on serum VD status has been in-
vestigated in several studies, although the results remain
inconclusive. Raimundo et al. [18] reported that a single
oral intake of 50,000 IU VD3 with a high-fat meal con-
taining 25.6 g fat/meal resulted in a significant increase
in serum 25(OH)D levels after 14 days, while there was
no significant change in 25(OH)D levels when VD was
taken with a low-fat meal (1.7 g fat/meal). Dawson-
Hughes et al. [19] observed that plasma VD3 level at 12
h after taking 50,000 IU VD3 tablet with a low-fat meal
(10% kcal, 11.1 g total fat) was 20% higher when com-
pared with the plasma VD3 levels after VD3 taken with
no meal or a high-fat meal (50% kcal, 35.2 g total fat).
Recent studies have suggested the possibility of VD ab-
sorption through protein-mediated diffusion by choles-
terol transporter proteins such as scavenger receptor
class B type 1 (SR-B1), cluster of differentiation 36
(CD36), and Niemann-Pick C1-Like 1 (NPC1L1) and
their expression levels could be affected by obesity or
the amount of fat intake [20, 21]. Therefore, in addition
to adiposity, dietary fat amount and the expression of
transporter proteins involved in VD absorption should
be considered for the circulatory 25(OH)D response to
VD intake.
The objective of this study was to investigate
whether obesity affects VD metabolism and tissue dis-
tribution when dietary VD was at deficient or supple-
mentation levels. To achieve this purpose, circulatory
and tissue levels of vitamin D and expression of genes
involved in vitamin D absorption and metabolism
were determined in obese and control mice fed different
levels of vitamin D.
Methods
Animals and diets
Six-week-old C57BL/6 male mice (Central Animal
Laboratory, Seoul, Korea) were housed in the specific-
pathogen-free animal facility at Seoul National Univer-
sity with environmentally controlled temperature (23 ±
1 °C), relative humidity (50 ± 10%), and a 12-h light/12-h
dark cycle. After 5 d of acclimation with the control diet,
the mice were assigned to 6 groups and fed control (10%
kcal fat, CON) or high-fat (45% kcal fat, HFD) diets
containing three different levels of VD3 [low (50 IU/kg
diet, LVd), control (1000 IU/kg diet, CVd), or high (25,
000 IU/kg diet, HVd)] ad libitum for 13 wk. (CON-LVd,
#119320; CON-CVd, #103816; CON-HVd, #119321;
HFD-LVd, #119318; HFD-CVd, #103818; HFD-HVd,
#119319; Dyets, Inc., Bethlehem, PA, USA) (See
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additional file 1: Table S1). Food intake was measured 4
times per week and body weight was recorded weekly.
Food intake in mice was measured by providing known
amount of food and subtracting the weight of remaining
food. At the end of the 13th week, the animals were
fasted for 12 h and two animals from each group were
anesthetized with 1.5 g/ kg urethane (intraperitoneal),
then scanned with a Hologic Discovery DEXA instru-
ment (Hologic, Toronto, ON, Canada). After 12 h of
fasting, all mice were euthanized by CO2 asphyxiation.
Blood, liver, small intestine (duodenum, jejunum, and
ileum), kidney, and adipose tissue were collected,
weighed, and stored at − 80 °C until analyzed.
Determination of liver triacylglycerol (TG) levels
Lipid was extracted from the liver according to the
method by Folch et al. [22], then liver TG levels were
determined using a commercial kit (Asan pharmaceut-
ical, Seoul, Korea) based on an enzymatic assay.
Determination of serum 25(OH)D levels
Serum 25(OH)D levels were measured via a radio-
immunoassay (RIA) using commercial RIA kit (DiaSorin,
Stillwater, MN, USA) according to the manufacturer’s
instructions. The radioactivity was measured with an
automatic gamma counter (2470 Wizard2, Perkin Elmer,
Shelton, CT, USA).
Determination of vitamin D3 and 25(OH)D3 levels in liver
and adipose tissue
Chemicals and reagents
VD3, 25(OH)D3, isotopically labeled 6, 19, 19 [d3]-VD3,
d3–25(OH)D3, methyl tert-butyl ether (MTBE), formic
acid (LC-MS grade), and ammonium formate (≥99.0%)
were purchased from Sigma-Aldrich (St. Louis, MO,
USA). Methanol, ethanol, and acetonitrile (AcN) were
liquid chromatography/mass spectrometry (LC/MS)-
grade and purchased from Fisher Scientific (Pittsburgh,
PA, USA). Ultra-pure water was prepared with LaboS-
tar™ TWF UV 7 (Siemens, MA, USA).
Sample preparation and PTAD derivatization
VD3 and 25(OH)D3 were analyzed from liver and adi-
pose tissue using a modification of the original method
by Lipkie et al. [12]. Quality control (QC) samples used
for the external standard curve were prepared from the
adipose tissue and liver of 22-week-old C57BL6 mice fed
a VD-deficient diet (50 IU VD3/kg diet). Detailed
procedure is described in additional file [Additional
file 1- Method].
LC-MS/MS analysis
A Shimadzu LCMS-8040 triple quadrupole mass spec-
trometer with a Shimadzu Nexara X ultra-high-
performance liquid chromatography (UHPLC; Kyoto,
Japan) system was used for the separation of PTAD-
derivatized VD3 and 25(OH)D3. In the UHPLC system,
a Kinetex® C18 column (100 × 2.1 mm, 2.6 μm, Phenom-
enex, Torrance, CA, USA) with a SecurityGuard™ Ultra
guard column (Phenomenex) was used to separate each
target analyte peak. The oven temperature was 40 °C.
Mobile phase A was 0.1% formic acid and 5mM methyl-
amine in water and B was 0.1% formic acid in methanol,
and the flow rate was 0.2 mL/min. The gradient for B
was started with 20% total volume and 30 s later, %B
was raised to 70% for 0.5 min, ramped to 99% for 17.5
min, and held for 3 min. Next, %B was dropped sharply
to 20% for 0.5 min and held for 5 min. The total run
time was 27min. The injection volume was 5 μL.
In the MS system, electrospray (ESI)-positive mode
was used for the ionization of the target compounds.
The nebulizing and drying gas (nitrogen) flows were 3
and 15 L/min, respectively. The desolvation line and heat
block temperature were 250 and 400 °C, respectively.
The collision-induced dissociation gas was argon. Sched-
uled multiple reaction monitoring (MRM) was used for
each analyte, and its detection window and dwell time
were ± 1min and 10 ms, respectively. LCMS software
(version 5.60, LabSolutions) was used for data
processing.
Validation of vitamin D3 and 25(OH)D3 quantification
method
To validate the accuracy of the method, liver or adipose
tissue was homogenized in PBS to 33% (w/w) solutions.
10 μL of internal standard (a mixture of d3-VD3 and
d3–25(OH)D3, 1 μg/ mL) was added to 400 μL of hom-
ogenate, then spiked with 10 μL of 2, 10, or 100 ng/ mL
of d3-VD3 and d3–25(OH)D3 mixture in AcN (final
spiked levels: 1.5, 7.5, or 75 ng/g tissue). The endogenous
VD3 level was determined from the sample with only
the internal standard added. Accuracy was evaluated
with 3 samples, repeated over 3 days, by the following
equation: (mean of measured value/QC sample value) ×
100%.
Within-day precision was determined by analyzing the
same liver and epididymal fat homogenates three separ-
ate times in 1 day. Between-day precision was deter-
mined by analyzing the same QC sample on 3 different
days. Precision was determined as the relative coefficient
of variation (%CV): (standard deviation/mean) × 100%.
RNA extraction and real time PCR
Total RNA was extracted using Trizol reagent (Invitro-
gen, Carlsbad, CA, USA). The quality of the RNA
sample was determined using agarose gel electrophoresis
with the Gel Doc XR system (Bio-Rad Laboratories,
Hercules, CA, USA), and the absorbance at 260 and 280
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nm with a nano-spectrophotometer (NANO-200,
BIOAND Co., Gyeonggi, Korea). cDNA was synthesized
using a PrimeScript™II 1st strand cDNA synthesis kit
(Takara Bio., Shiga, Japan) with a thermal cycler (Ap-
plied Biosystems, Foster City, CA, USA). mRNA levels of
cytochrome P450 2R1 (Cyp2r1), cytochrome P450 27A1
(Cyp27a1), low density lipoprotein receptor-related pro-
tein 1 (Lrp1), and VD binding protein (Dbp) in the liver,
lipoprotein lipase (Lpl) in the adipose tissue, microsomal
triglyceride transfer protein (Mttp), cluster of differen-
tiation 36 (Cd36), scavenger receptor class B member 1
(Sr-b1), Niemann-Pick C1-Like 1 (Npc1l1), and ATP-
binding cassette transporter (Abca1) in the jejunum were
determined using real-time PCR with SYBR Premix Ex
Taq (Takara bio.) and StepOne Real-time PCR System
(Applied Biosystems). All values were normalized to the
levels of Gapdh and expressed as relative mRNA level
compared to the average level of the CON-CVd group.
The sequences of primers used in this study are
presented in Additional file 1: Table S2.
Statistical analyses
All data were analyzed using SPSS statistical software
version 23.0 (IBM SPSS Statistics, Chicago, IL, USA).
Normality in distribution was determined based on the
results of a Shapiro-Wilk test and Q-Q plot. For data
not following the normal distribution (Sr-b1 and Lpl),
square root transformation was done for statistical ana-
lysis. To evaluate the overall effects of dietary fat amount
and VD content, and their interaction, comparisons were
made by two-way ANOVAs. Further individual compari-
sons among groups were done by Fisher’s least signifi-
cant difference post hoc test. For analyses of correlations
between serum 25(OH)D level (dependent variable) and
other factors, Pearson’s correlation was used to
determine the association between parameters. All data
are presented as means ± SEMs and P < 0.05 was consi-
dered as statistically significant.
Results
Body weight, adipose tissue and liver weights, food
intake, and liver TG levels
There was no significant difference in body weight at
week 0 among the groups. The HFD groups had
38.7% higher body weight (P < 0.001) and 107.4%
higher white adipose tissue weight (P < 0.001) com-
pared with the CON groups. Overall, there was no
statistically significant effect of dietary VD content on
body weight and adipose tissue weight (Table 1), and
the average daily food intake (g/day) was not affected
by dietary VD content or fat amount. Based on the
VD content of the experimental diets and daily food
intake (g/day), the actual daily VD intake (IU/day)
calculated was 0.15, 2.8, or 71.3 IU/day in the CON
groups (LVd, CVd, or HVd, respectively) and 0.18,
3.7, or 82.5 IU/day in the HFD groups (LVd, CVd, or
HVd, respectively). Liver weight per body weight (g/
100 g body weight) and liver TG levels were signifi-
cantly higher in the HFD groups than the CON
groups. Overall, VD content in the diet did not affect
the liver weight or liver TG levels.
Serum 25(OH)D concentration
Overall, dietary VD content had a significant effect
(P < 0.001) on serum 25(OH)D levels (Fig. 1). The aver-
age values of serum 25(OH)D were 10.8 ng/mL in LVd
group, 26.7 ng/mL in CVd group, and 74.9 ng/mL in
HVd group. An increase in dietary VD content resulted
in higher serum 25(OH)D levels in both the CON and
HFD groups; however, the 25(OH)D levels showed
Table 1 Body weight (wt.), white adipose tissue (WAT) wt., dietary intake, liver wt., and liver TG levels in the CON and HFD groups



















Body wt. at 0 wk. (g) 22.6 ± 0.4 23.1 ± 0.4 23.2 ± 0.2 22.7 ± 0.3 22.6 ± 0.2 22.7 ± 0.7 0.24 0.56 0.49
Body wt. at 13 wk.
(g)
35.8 ± 1.0a 35.0 ± 0.4a 34.5 ± 1.1a 49.5 ± 0.7c 49.5 ± 0.9c 46.7 ± 0.8b < 0.001 0.06 0.42
WAT wt2 (g) 2.91 ± 0.31a 2.74 ± 0.22a 2.64 ± 0.29a 5.59 ± 0.09b 5.90 ± 0.11b 5.70 ± 0.21b < 0.001 0.79 0.50
Daily food intake (g/
day)
2.96 ± 0.04 2.92 ± 0.05 2.98 ± 0.04 3.03 ± 0.05 3.11 ± 0.11 2.80 ± 0.05 0.66 0.18 0.036
Liver wt./body wt.
(%)
3.23 ± 0.14a 3.41 ± 0.14a 3.34 ± 0.09a 5.24 ± 0.13c 4.74 ± 0.23bc 4.37 ± 0.29b < 0.001 0.16 0.038
Liver TG levels
(mg/g tissue)
57.2 ± 5.0a 54.6 ± 8.7a 63.6 ± 6.4a 138.3 ± 10.1b 127.7 ± 12.9b 111.7 ± 12.8b < 0.001 0.62 0.28
1 Two-way ANOVA was used to determine the significant effects of fat amount and vitamin D content, and an interaction. abDifferent superscripts indicate
significant difference (P < 0.05) by Fisher’s LSD multiple comparison test. Data are presented as means ± SEMs. 2White adipose tissue weight included epididymal,
subcutaneous, retroperitoneum, and perinephric fats. CON 10% kcal fat diet, HFD 45% kcal fat diet; LVd Low vitamin D, CVd Control vitamin D, HVd High vitamin D
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different patterns between the two depending on the
dietary VD content (interaction, P < 0.001). In the LVd
groups, the serum 25(OH)D level tended to be higher in
the HFD-LVd group compared with the CON-LVd
group (P = 0.05, 76.6% higher). On the other hand, when
the VD level in the diet was at a supplementary level,
the HFD-HVd group had significantly lower serum
25(OH)D level than the CON-HVd group (P < 0.001,
19.7% lower), in spite of higher daily VD intake in HFD-
HVd group (82.5 IU/day) compared with the CON-HVd
group (71.3 IU/day). Serum 25(OH)D levels in HVd
group negatively correlated with body weight (g) and
white adipose tissue (g) (r = − 0.762, P < 0.01; r = − 0.833,
P < 0.01, respectively). With the control level of dietary
VD (in the CVd groups), there was no significant differ-
ence in the serum 25(OH)D concentration between the
CON-CVd and HFD-CVd groups.
The mRNA levels of genes involved in vitamin D
absorption in small intestine
The expression levels of cholesterol transporter genes
(Cd36, Sr-b1, Npc1l1, and Abca1) and Mttp in the je-
junum were determined to investigate the effects of diet-
ary VD content or fat amount on VD absorption in the
small intestine (Fig. 2A). Among the cholesterol trans-
porter genes, the mRNA levels of Abca1 in the jejunum
were significantly higher and Cd36 mRNA levels tended
to be higher (P = 0.08) in the HFD groups compared
with the CON groups, but the mRNA levels of Sr-b1
were significantly lower. The expression levels of Mttp
(essential for the assembly of apolipoproteins and lipid
into chylomicrons) in the jejunum were higher in the
HFD groups than the CON groups (P = 0.002). Dietary
VD content did not affect the expression of genes
involved in VD absorption.
The mRNA levels of genes involved in vitamin D transport
The expression of genes involved in the chylomicron hy-
drolysis and VD transport was determined. mRNA levels
of epididymal Lpl were significantly lower in the HFD
groups than the CON groups, while dietary VD content
had no effect on epididymal Lpl expression levels.
mRNA levels of liver Lrp1 and Dbp were not signifi-
cantly affected by either dietary fat amount or VD
contents (Fig. 2B).
Liver and adipose tissue vitamin D3 and 25(OH)D3 levels
Optimization of analytical instrument condition and
method validation
For the PTAD-derivatized target compounds (VD3, d3-
VD3, 25(OH)D3, and d3–25(OH)D3), a full scan analysis
was conducted in which both of them were ionized with
protons ([M +H]+) in ESI-positive mode. Those in
ionization form were selected as the precursor ions, and
a product ion scan was performed with various collision
energy levels to select the quantifier ions by considering
sensitivity and selectivity. MRM transitions and reten-
tion time (tR) for PTAD-VD3, PTAD-25(OH)D3, and
their internal standards are given in an Additional file 1:
Table S3. Using the matrix-matched standard, the limits
of quantitation (LOQs) of VD3 and 25(OH)D3 were de-
termined with a signal-to-noise ratio ≥ 10 for each peak
in the chromatogram. The LOQs of VD3 and 25(OH)D3
Fig. 1 Serum 25(OH)D levels (ng/mL). Data are presented as means ± SEMs, n = 6 for each group. Two-way ANOVA was used to determine the
significant effects of dietary fat amount and vitamin D content, and an interaction. abDifferent superscripts indicate significant difference (P < 0.05)
by Fisher’s LSD multiple comparison test. CON: 10% kcal fat diet; HFD: 45% kcal fat diet; LVd: Low vitamin D; CVd: Control vitamin D; HVd: High
vitamin D
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in the liver and adipose tissue samples were 1 ng/mL. The
linear ranges for the samples were 1~1000 ng/mL and cor-
relation coefficients (r2) were determined for the linearity
of the calibration curve; r2 for both liver and adipose tissue
was ≥0.990.
The accuracy determined from the levels of three
spikes (1.5, 7.5, and 75 ng/g tissue) was 96 ~ 103%
and 97 ~ 107% in adipose tissue and 96 ~ 107% and
96 ~ 103% in liver tissue for VD3 and 25(OH)D3, re-
spectively (Additional file 1: Table S4). The precision
(within-day and between-day) of VD3 and 25(OH)D3
from liver and adipose tissue is shown in Table S5 in
the Additional file 1.
Concentration and total amount of vitamin D3 in liver and
epididymal adipose tissue
VD3 concentration (ng/g tissue) and total amount (ng) in
liver and epididymal adipose tissue are reported in Table 2.
In the liver and adipose tissue, VD3 levels were under the
LOQ in the LVd groups but were 43 and 85 times higher,
respectively, in the CON-HVd group compared with the
CON-CVd group and 72 and 124 times higher, respect-
ively, in the HFD-HVd group compared to the HFD-CVd
group. The dietary fat amount did not have a significant
effect on VD3 level per weight in liver and adipose tissue,
but its effect on the total amount in the tissue was
different depending on the dietary VD content.
Fig. 2 The mRNA levels of genes involved in (A) vitamin D absorption in jejunum and (B) vitamin D transport in epididymal adipose tissue and
liver. Data are presented as means ± SEMs, n = 6 ~ 8 for each group. Two-way ANOVA was used to determine the significant effects of dietary fat
amount and vitamin D content, and an interaction. abDifferent superscripts indicate significant difference (P < 0.05) by Fisher’s LSD multiple
comparison test. CON: 10% kcal fat diet; HFD: 45% kcal fat diet; LVd: Low vitamin D; CVd:Control vitamin D; HVd: High vitamin D, Cd36, cluster of
differentiation 36; Sr-b1, Scavenger receptor class B type1; Npc1l1, Niemann-Pick C1-Like 1; Abca1, ATP-binding cassette transporter A1; Mttp,
Microsomal triglyceride transfer protein; Lpl, lipoprotein lipase; Lrp1, Low density lipoprotein receptor-related protein 1; Dbp, vitamin D
binding protein
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For the total VD3 amount in liver and adipose tissue,
there was a significant interaction between the dietary
fat amount and VD content (P < 0.01). In the HVd
groups, the total amount of VD3 in the liver and adipose
tissue were significantly higher in the HFD-HVd group
(121 and 44%, respectively) compared with the CON-
HVd group. The total amount of VD3(g) in adipose
tissue in HVd groups showed negative correlation with
serum 25(OH)D levels (ng/ mL) (r = − 0.629, P < 0.05)
(Fig. 3a). However, when mice were fed the control level
of VD (the CVd groups), dietary fat content did not
affect the VD3 amount in liver and adipose tissue. In
CVd groups, no significant correlation between the total
adipose tissue VD3 amount (g) and serum 25(OH)D
(ng/mL) was observed (Fig. 3b).
Concentration and total amount of 25(OH)D3 in liver and
epididymal adipose tissue
The 25(OH)D3 concentration (ng/g tissue) and total
amount (ng) in liver and adipose tissue are summarized
in Table 3. Liver and adipose tissue 25(OH)D3 concen-
trations in the LVd groups were < 1 ng/g tissue but
were 5.6 times higher in the liver in the CON-HVd
group compared to the CON-CVd group (P < 0.05),
and 3.3 times higher in HFD-HVd group than in HFD-
CVd group. There was an interaction between the
dietary fat amount and VD content regarding liver
25(OH)D3 levels: the level was significantly lower in
the HFD-HVd group compared with the CON-HVd
group, which was not observed in the CVd groups.
Liver 25(OH)D3 levels (ng/g tissue) correlated posi-
tively with serum 25(OH)D levels (ng/mL) (r = 0.871,
P < 0.001) (Fig. 3c). In epididymal adipose tissue,
25(OH)D3 concentration was higher in the HVd groups
compared with the CVd groups (P < 0.05). The dietary
fat amount had no significant influence on adipose
tissue 25(OH)D3 concentration.
The mRNA levels of 25-hydroxylases in liver and
epididymal adipose tissue
Neither dietary fat amount nor dietary VD content had a
significant impact on liver mRNA levels of Cyp2r1 and
Cyp27a1 (Fig. 4). On the other hand, the mRNA levels
of epididymal fat Cyp2r1 was higher (P = 0.026) and
epididymal fat Cyp27a1 was lower (P = 0.003) in the
HFD groups compared with the CON groups.
Discussion
This study showed that obesity differentially affected
serum 25(OH)D levels and the total VD amount in the
liver and adipose tissue depending on the levels of VD in
the diet. When VD intake was at a supplementary level,
high-fat diet-induced obesity resulted in a greater
amount of VD3 storage in liver and epididymal adipose
tissue compared with the non-obese control, and this
could contribute to low serum 25(OH)D levels. How-
ever, when VD intake was at a physiological level, there
was no significant difference in the serum 25(OH)D
levels between the obese and the control mice.
Serum 25(OH)D has a half-life of approximately 15
days and is the best indicator for the nutritional status
of VD, and our results confirm a dose-response rela-
tionship of serum 25(OH)D and dietary VD levels [23,
24]. When VD content was at 50 IU VD/kg diet (the
LVd group), the serum 25(OH)D level was 59% lower
than that in the CVd group (1000 IU VD/kg diet; the
National Research Council’s nutrient requirement).
With a supplementary level of VD (25,000 IU VD/kg
diet; the HVd group), the serum 25(OH)D level was
180% higher compared with the CVd group. These re-
sults are consistent with many previous studies which
have reported a positive correlation between dietary
VD intake and circulating 25(OH)D levels in humans
[24, 25] and rodents [26, 27].
The VD levels in liver and adipose tissue correlated
positively with dietary VD content. Some previous















Liver Vitamin D3 level
(ng/g tissue)
14.53 ± 3.0a 11.09 ± 2.9a 628.3 ± 74.7b 797.0 ± 105.3b 0.210 < 0.001 0.192
Total Vitamin D3
amount (ng)





3.80 ± 0.44 a 2.50 ± 0.50 a 327.4 ± 61.57
b
310.5 ± 28.95 b 0.768 < 0.001 0.806
Total Vitamin D3
amount (ng)
4.68 ± 0.54a 3.87 ± 0.71 a 385.4 ± 45.1b 554.3 ± 23.3c 0.002 < 0.001 0.002
1Two-way ANOVA was used to determine the significant effects of fat amount and vitamin D content, and an interaction. abDifferent superscripts indicate
significant difference (P < 0.05) by Fisher’s LSD multiple comparison test. Data are presented as means ± SEMs
2CON 10% kcal fat diet, HFD 45% kcal fat diet, CVd Control vitamin D, HVd High vitamin D
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studies have also shown that dietary VD increases tissue
VD and 25(OH)D levels in a dose-dependent manner
[12, 28]. VD3 levels (ng/g tissue) in the adipose tissue
from the CON-HVd and HFD-HVd groups were 85 and
124 times higher than those from the CON-CVd and
HFD-CVd groups, while adipose tissue 25(OH)D3 levels
(ng/g tissue) were 5.3 and 2.4 times higher, respectively,
in CON-HVd and HFD-HVd groups compared with the
CON-CVd and HFD-CVd groups. These results indi-
cated that supplementary VD is mostly reflected in
tissue VD3 levels rather than 25(OH)D levels in serum
or tissue. Lipkie et al. [12] reported that VD3 levels in
rat liver and adipose tissue were 3.9 and 7.6 ng/g tissue,
respectively, and 25(OH)D levels in liver and adipose tis-
sue were less than 1 ng/g tissue when rats were fed 740
IU VD3/ kg diet for 8 wk. The VD3 concentrations in
pigs fed 2000 IU VD3/day were 2.7 ng/g tissue in liver
tissue and 7 ng/g tissue in adipose tissue [29]. VD and
25(OH)D levels from previous studies were similar to
the levels observed in the CVd group in this study.
Depending on the dietary VD levels, the fat amount in
the diet had differential effects on serum 25(OH)D
levels. When dietary VD content was low (LVd groups)
or at a control level, dietary fat intake did not affect
serum 25(OH)D levels. However, in the HVd group,
HFD-HVd group had significantly lower 25(OH)D level
compared with CON-HVd group and serum 25(OH)D
showed negative correlations with body weight and
white adipose tissue weight. Since liver 25-hydroxylase
mRNA levels were not different among the groups, the
differences in serum 25(OH)D levels could be due to dif-
ferences in the amount of absorbed VD, which serves as
a substrate for 25(OH)D synthesis in liver. The effects of
HFD-induced obesity on serum 25(OH)D levels and liver
25-hydroxylases are not well characterized and still re-
main contradictory. When mice were fed HFD with a
control level of vitamin D, several studies reported no
significant decrease of serum 25(OH)D [30–32] which is
consistent with the results from this study, but decreased
level of blood 25(OH)D followed by low liver Cyp2r1
mRNA level in female obese mice was also reported
[33]. Not only the expression level but also activity and
genetic variants of liver Cyp2r1 are important factors in
vitamin D metabolism [34, 35], therefore, further studies
focused on the role of 25-hydroxyases in obesity are
needed.
In spite of 16% higher VD intake (IU/g) in HFD-HVd
group compared with CON-HVd group, the serum
25(OH)D level was significantly lower (19% lower) in the
HFD-HVd group. HFD-HVd group’s total VD3 amount
in the liver and epididymal adipose tissue were 121 and
44% higher, respectively, compared with the CON-HVd
group. Since epididymal adipose tissue accounts for less
than 20% of total body adipose tissue, total body fat
mass was estimated using a DEXA scan data. Average
total body fat mass of the HFD-HVd group was 11.6 g
and that of the CON-HVd group was 5.2 g [See add-
itional file 1: Table S6]. By using the epididymal fat VD3
level (ng/g tissue) and total body fat mass, the estimated
total adipose tissue VD3 amount was calculated and it
was 192% higher in the HFD-HVd group than that in
the CON-HVd group (8187 vs. 2799 ng, respectively).
These results suggested that obesity could lead to a lar-
ger amount of VD stored in the liver and adipose tissue,
which could contribute to a low serum 25(OH)D level
when VD intake was at a supplementary level. However,




Fig. 3 Correlations between serum 25(OH)D levels (ng/mL) and
adipose tissue vitamin D3 amount in HVd groups (a) and CVd
groups (b) and liver 25(OH)D3 levels (ng/g tissue)(c) n = 11 ~ 28,
Pearson correlation coefficient, r, and P value are indicated
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therefore total adipose tissue VD amount based on
DEXA is a rough estimation. The limitation of this study
is that subcutaneous fat VD content was not measured.
There are mixed results regarding the VD content in the
subcutaneous and visceral fat. Carrelli et al. [13] re-
ported that VD concentration was higher in omental fat
compared with subcutaneous fat in human subjects,
while Lawson et al. [36] found that VD in perirenal fat
(visceral fat) was lower than in axillary fat (subcutaneous
fat). Therefore, further studies are needed for the accur-
ate estimation of total adipose tissue VD amount. Never-
theless, results from this study shows that more VD is
stored in the liver and epididymal adipose tissue due to
fatness.
Wortsman et al. [10] also reported that the serum
25(OH)D level was lower in obese persons than non-
obese persons after a supplementary high dose of VD
(50,000 IU); they assumed that this could be due to VD
sequestration in the adipose tissue, however, VD in the
tissue was not measured in their study. In this study, by
quantifying VD from liver and adipose tissue, it was con-
firmed that increased tissue VD amount in obesity could
contribute to a lower the serum 25(OH)D level when
VD was at a supplementary level. However, contrary to
the HVd groups, there was no significant difference in
the liver and adipose tissue VD amount between the
CON-CVd and HFD-CVd groups. According to Heaney
et al. [37], dietary VD is slowly converted to circulating


















7.47 ± 0.43a 8.24 ± 0.67a 41.9 ± 3.5c 27.0 ± 3.0b 0.004 < 0.001 0.002
Total 25(OH)D3
amount (ng)






3.43 ± 0.43 a 8.03 ± 1.52 a 18.1 ± 2.2
b
19.5 ± 2.1 b 0.089 < 0.001 0.364
Total 25(OH)D3
amount (ng)
4.41 ± 0.77a 12.5 ± 2.1b 22.4 ± 3.0c 35.9 ± 3.9d 0.001 < 0.001 0.334
1Two-way ANOVA was used to determine the significant effects of fat amount and vitamin D content, and an interaction. abDifferent superscripts indicate
significant difference (P < 0.05) by Fisher’s LSD multiple comparison test. Data are presented as means ± SEMs.2CON 10% kcal fat diet, HFD 45% kcal fat diet, CVd
Control vitamin D, HVd High vitamin D
Fig. 4 The mRNA levels of 25-hydroxylases in liver and epididymal fat tissue. Data are presented as means ± SEMs, n = 6 for each group. Two-way
ANOVA was used to determine the significant effects of dietary fat amount and vitamin D content, and an interaction. abDifferent superscripts
indicate significant difference (P < 0.05) by Fisher’s LSD multiple comparison test. CON: 10% kcal fat diet; HFD: 45% kcal fat diet; LVd: Low vitamin
D group; CVd: Control vitamin D group; HVd: High vitamin D group. Cyp2r1, cytochrome P450 2R1; Cyp27a1, cytochrome P450 27A1
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25(OH)D and VD seemed to be stored in adipose tissue
when VD input is high whereas there is rapid conversion
of VD to 25(OH)D when VD input is at a physiologic
level (a daily input of 2000 IU). Therefore, the results
from this study and others suggest that serum 25(OH)D
could be lower in the obese due to VD distribution into
a larger mass of adipose tissue rather than sequestration,
and the rate at which VD is distributed to the blood
and adipose tissue could be dependent on dietary VD
content.
Contrary to the VD-supplemented groups, animals fed
the deficient level of VD (50 IU/kg diet) with HFD
tended to have a higher serum 25(OH)D level compared
with the CON-LVd group (P = 0.054). The tissue VD
levels of the VD-deficient groups could not be deter-
mined because of the low levels of VD (under LOQ < 1
ng/g tissue) present in the tissue. Another limitation of
this study is that the association between serum
25(OH)D and tissue VD levels could not be determined
when dietary VD was at a deficient level. VD is preferen-
tially stored in the blood and rapidly converted to
25(OH)D with low VD intake rather than being stored
in the body fat [37]. A previous study has also reported
that tissue VD or 25(OH)D levels in rats fed 49 IU ergo-
calciferol (VD2) for 8 weeks were lower than 2 or 0.5 ng/g
tissue, respectively [12]. Therefore, it is possible that
most of the absorbed dietary VD was converted to
serum 25(OH)D in mice fed a 50 IU VD/kg diet.
Serum 25(OH)D level of HFD-LVd group was 78.2%
higher than that of CON-LVd group, although the
amount of daily VD intake was 17% higher in the HFD-
LVd group compared to the CON-LVd group. Therefore,
tendency of higher serum 25(OH)D level in HFD-LVd
group than CON-LVd group could be ascribed to various
factors such as adiposity or the fat content of a meal as
well as the amount of dietary VD intake. There are two
possible mechanisms which could have contributed to this
higher VD absorption in HFD-LVd group. First, high fat
content in the diet could have increased the absorption of
VD. Dietary fat has been reported to stimulate bile acid se-
cretion and consequently enhance VD absorption [38].
Higher serum 25(OH)D levels was observed when people
took VD with a high-fat meal [18] and it was reported that
more VD was absorbed when taken with fat-containing
meal than fat-free meal [39]. However, more studies are
needed to determine the influence of dietary fat on VD ab-
sorption because the effect of fat on VD absorption was
not identified in some study [40] and correlation between
dietary fat amount and VD absorption was not found [19].
Second, the jejunal mRNA levels of the genes involved in
VD absorption and chylomicron formation in small intes-
tine were higher in the HFD groups compared with the
CON groups. MTP is essential for chylomicron formation
and it increases fat absorption at small intestine [15, 41],
and mRNA level of Mttp was significantly higher in HFD
group than in CON group, especially HFD-LVd group
showed 32% higher levels of Mttp compared with the
CON-LVd group. This result is consistent with previous
study in which increased Mttp mRNA and protein levels
in jejunum of HFD-induced obese animal were observed
[42–45], therefore it is suggested that HFD-induced obes-
ity could have contributed to the increase in VD absorp-
tion by increasing fat absorption. In addition, it has been
recently reported that VD is absorbed into the intestine
not only by passive diffusion but also by cholesterol trans-
porter proteins [20, 21]. In this study, mRNA levels of
Abca1 were higher, Cd36 tended to be higher, and Sr-b1
were lower in HFD groups compared with CON groups.
There is a possibility that obesity could have affected VD
absorption through cholesterol transporters. Higher Cd36
mRNA levels been reported in obese mice [45]. It is hard
to figure out the effect of changes in Sr-b1 on VD absorp-
tion, because SR-B1 has been reported to be involved in
both influx and efflux of VD at the intestinal apical mem-
brane [20]. Therefore, further studies including protein
expression are needed to elucidate the role of each
cholesterol transporter in VD transport.
Conclusion
At supplementary level of VD intake, high fat diet-
induced obesity resulted in lower serum 25(OH)D levels
than the lean control. A significant amount of dietary VD
is stored in the liver and adipose tissues when VD is at a
supplementary level; thus excess body adiposity could
contribute to lower serum 25(OH)D level. Whereas, when
VD in the diet is at a control (NRC requirement, 1000 IU/
kg diet) level, there was no significant effect of obesity on
tissue VD amount and serum 25(OH)D levels. These
finding have expanded our knowledge that dietary VD
distribution into the blood and adipose shows differential
response to dietary vitamin D intake depending on the
adiposity. In addition, there is a possibility that obese sub-
jects will have to increase their VD intake when supple-
menting VD, if they expect the same effect as non-obese
subjects.
Supplementary information




25(OH)D: 25-hydroxyvitamin D; 25(OH)D3: 25-hydroxycholecalciferol;
Abca1: ATP-binding cassette transporter; AcN: Acetonitrile; CD36: Cluster of
differentiation 36; CON: Control diet; CV: Coefficient of variation; CVd: Control
vitamin D; Cyp2r1: Cytochrome P450 2R1; Cyp27a1: Cytochrome P450 27A1;
Dbp: Vitamin D binding protein; HFD: High-fat diet; HVd: High vitamin D; LC/
MS: Liquid chromatography/mass spectrometry; LPL: Lipoprotein lipase;
LOQ: Limit of quantitation; Lrp1: Low density lipoprotein receptor-related
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